Description
Benefits
- Sensitive: The Clearview Malaria® Combo detects HRP-2 and P.aldolase and can differentiate a potentially deadly P.f. infection from an infection caused by other malarial parasites
- Rapid: The test yields results in 15 minutes
- Cost effective: By delivering quick and accurate results, RDTs can help improve the quality of patient care and reduce overprescription of anti-malaria drugs
- Easy to use: The Clearview® Malaria Combo uses venous or capillary whole blood and requires no additional instruments, microscopy, or laboratory infrastructure
Specifications
- Sensitivity for Non-P.f. malaria: 91.4%
- Sensitivity for P.f. malaria: 96.0%
- Overall specificity: 99.7%
- Method: Lateral Flow
- Sample Size: 5μL
- Sample Type: Whole blood
- Storage: 4°C – 40°C
- Shelf Life: 24 months
References
1. World Health Organisation (cited Feb 2006). RBM Fact Sheet: What is Malaria? [www.rbm.who.int] Roll Back Malaria Partnership Secretariat, WHO
2. The Global Fund (cited Feb 2006). Fighting Malaria: The Global Malaria Epidemic [www.theglobalfund.org/en/malaria/?lang=en]
3. Rapid-diagnostics.org (cited Feb 2006). Rapid Diagnostic Tests for Malaria: About Malaria. [www.rapid-diagnostics.org/rti-malaria.htm] PATH
4. World Health Organisation. Guidelines for the treatment of malaria. Second Edition 2010
5. Brieger WR (2009) Rapid diagnostic tests can improve the quality of malaria case management Africa Health Vol 31 No 6; 13-16
6. Chanda P et al (2009) Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia. Cost Eff Resour Alloc 8:7:5
